Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trialFei Ma, Binghe Xu, Qiang Liu et al.|BMJ|2023Cited by 82
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Xiaoling Xu, Binqing Fu et al.|Frontiers of Medicine|2021Cited by 80
Allogeneic double‐negative T cell therapy for relapsed <scp>acute myeloid leukemia</scp> patients post <scp>allogeneic hematopoietic stem cell transplantation</scp>: A first‐in‐human phase I studyBaolin Tang, Xiaoyu Zhu, Jong Bok Lee et al.|American Journal of Hematology|2022Cited by 26
Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter TrialDongsheng Wang, Xiaoling Xu, Binqing Fu et al.|SSRN Electronic Journal|2020Cited by 18
CNP-MoS2@HA nanocomposite promotes neurovascular recovery through sustained release and cell cycle navigation in neurogenic erectile dysfunctionShijun Fu, Huan Feng, Peng Hu et al.|Chemical Engineering Journal|2025Cited by 3